 Constellation Pharmaceuticals NASDAQ:CNSTs stock had its buy rating reaffirmed by investment analysts at Jefferies Financial Group in a research report issued to clients and investors on Sunday, AnalystRatings.com reports. A number of other brokerages also recently issued reports on CNST. BidaskClub downgraded shares of Constellation Pharmaceuticals from a sell rating to a strong sell rating ... 